Key points
  1. CRS is a common condition in most of the world, leading to a significant burden on society in terms of healthcare consumption and productivity loss.
  2. Most current drugs are used to alleviate inflammation of the nasal mucosa, with no specific effect on promoting the epithelization or cilia growth of the nasal mucosa.
  3. Rh-bFGF can promote division and maintain the growth of cells from various tissues. However, there is no research regarding the effect of rh-bFGF on the growth of nasal mucosa or cilia after sinusitis surgery.
  4. Rh-bFGF nasal-drops and sprays can quickly and effectively relieve postoperative symptoms and improve long-term prognosis of patients with CRSwNP.
  5. Rh-bFGF nasal-drops are also an effective method for postoperative patients with eosinophilic CRSwNP.